These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 20564150)
81. Survival and prognostic factors after adjuvant Olesinski J; Mithieux F; Guillaud O; Hilleret MN; Lombard-Bohas C; Henry L; Boillot O; Walter T; Partensky C; Paliard P; Valette PJ; Vuillez JP; Borson-Chazot F; Scoazec JY; Dumortier J Ann Nucl Med; 2017 Jun; 31(5):379-389. PubMed ID: 28342103 [TBL] [Abstract][Full Text] [Related]
82. Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: results of phase II trial. Raoul JL; Boucher E; Olivie D; Guillygomarc'h A; Boudjema K; Garin E Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):745-50. PubMed ID: 16289908 [TBL] [Abstract][Full Text] [Related]
83. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Madsen MT Cancer Chemother Pharmacol; 1989; 23 Suppl():S54-8. PubMed ID: 2538267 [TBL] [Abstract][Full Text] [Related]
84. Case report: localization of lipiodol-radioiodine in hepatic metastases from renal cell carcinoma. Stansby G; Bhattacharya S; Hilson AJ; Lane DM; Hobbs KE Br J Radiol; 1994 Aug; 67(800):822-4. PubMed ID: 8087492 [TBL] [Abstract][Full Text] [Related]
85. Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial. Chung AY; Ooi LL; Machin D; Tan SB; Goh BK; Wong JS; Chen YM; Li PC; Gandhi M; Thng CH; Yu SW; Tan BS; Lo RH; Htoo AM; Tay KH; Sundram FX; Goh AS; Chew SP; Liau KH; Chow PK; Tay KH; Tan YM; Cheow PC; Ho CK; Soo KC World J Surg; 2013 Jun; 37(6):1356-61. PubMed ID: 23463394 [TBL] [Abstract][Full Text] [Related]
86. Dosimetric evaluation and therapeutic response to internal radiation therapy of hepatocarcinomas using iodine-131-labelled lipiodol. Becker S; Laffont S; Vitry F; Rolland Y; Lecloirec J; Boucher E; Raoul JL; Herry JY; Bourguet P; Garin E Nucl Med Commun; 2008 Sep; 29(9):815-25. PubMed ID: 18677210 [TBL] [Abstract][Full Text] [Related]
87. Development of Semiautomated Module for Preparation of Mukherjee A; Subramanian S; Ambade R; Avhad B; Dash A; Korde A Cancer Biother Radiopharm; 2017 Feb; 32(1):33-37. PubMed ID: 28128645 [TBL] [Abstract][Full Text] [Related]
88. Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma. Huang PW; Tsai SC; Luo TY; Kao CH; Lin WY Ann Nucl Med; 2013 Jul; 27(6):532-7. PubMed ID: 23479326 [TBL] [Abstract][Full Text] [Related]
89. Radiation exposure and radiation protection of the physician in iodine-131 Lipiodol therapy of liver tumours. Risse JH; Ponath C; Palmedo H; Menzel C; Grünwald F; Biersack HJ Eur J Nucl Med; 2001 Jul; 28(7):914-8. PubMed ID: 11504090 [TBL] [Abstract][Full Text] [Related]
90. Preparation of [131I]lipiodol as a hepatoma therapeutic agent. Lo JG; Wang AY; Wei YY; Lui WY; Chi CW; Chan WK Int J Rad Appl Instrum A; 1992 Dec; 43(12):1431-5. PubMed ID: 1334953 [TBL] [Abstract][Full Text] [Related]
91. Ablation of recurrent primary liver cancer using 131I-lipiodol. Novell R; Hilson A; Hobbs K Postgrad Med J; 1991 Apr; 67(786):393-5. PubMed ID: 1648718 [TBL] [Abstract][Full Text] [Related]
92. Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat. Garin E; Denizot B; Roux J; Noiret N; Lepareur N; Moreau M; Mesba H; Laurent JF; Herry JY; Bourguet P; Benoit JP; Lejeune JJ Lab Anim; 2005 Jul; 39(3):314-20. PubMed ID: 16004691 [TBL] [Abstract][Full Text] [Related]
93. Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetry. Risse JH; Pauleit D; Palmedo H; Bender H; Bucerius J; Ezziddin S; Klein V; Grünwald F; Biersack HJ; Reichmann K Nuklearmedizin; 2007; 46(5):192-7. PubMed ID: 17938753 [TBL] [Abstract][Full Text] [Related]
94. Transarterial Radioembolization (TARE) with Patel A; Subbanna I; Bhargavi V; Swamy S; Kallur KG; Patil S South Asian J Cancer; 2021 Apr; 10(2):81-86. PubMed ID: 34568220 [No Abstract] [Full Text] [Related]
95. Re: 188rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma--a case report. London L Ann Acad Med Singap; 2002 Jan; 31(1):132. PubMed ID: 11885488 [No Abstract] [Full Text] [Related]
100. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma. Uccelli L; Pasquali M; Boschi A; Giganti M; Duatti A Nucl Med Biol; 2011 Feb; 38(2):207-13. PubMed ID: 21315276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]